Degarelix
Also known as: Firmagon
Clinical Status
FDA Approved — advanced prostate cancer.
Mechanism of Action
A GnRH antagonist that immediately blocks GnRH receptors in the pituitary without causing initial testosterone flare. Rapidly reduces LH, FSH, and testosterone levels within days.
Dosing Defaults
Dose
240 mg loading, then 80 mg monthly
Frequency
Monthly (after loading dose)
Administration
Subcutaneous injection (abdomen)
Timing
Clinic visit
Food
with or without
Duration
Per oncology protocol
Dose range: 80-240 mg per injection
Monthly depot injection — timing within day is not critical.
Side Effects
- •Injection site reactions (40%)
- •Hot flashes
- •Weight gain
- •Fatigue
- •Elevated liver enzymes
- •QT prolongation
Contraindications & Warnings
- ⚠Severe hepatic impairment
- ⚠QT prolongation
- •Not medical advice
- •Monitor liver function and ECG
Compare
Compare Degarelix with another peptide side-by-side.
Ad
Related Hormonal Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.